Reimbursement. Access. Disease Specific Solutions.
RADical Group’s experience in understanding and leveraging managed markets is second to none when it comes to results — gaining favorable formulary positioning, overcoming administrative barriers, and aligning messaging with your brand team for maximum market traction. Below are some representative success stories.
RADical Group pioneered the concept of “body of evidence” — driving timely decision-making by pulling together relevant research into a single, easy-to-navigate format. To assist clinical pharmacists in evaluating Actos, a once-a-day medication for type 2 diabetes, RADical created a Clinical Resource Guide from key clinical abstracts. The guide grouped studies into disease, economic, and Actos trials so clinical pharmacists could quickly locate the information they needed.
How could Amitiza capitalize on a new MOA and several advanced clinical attributes? RADical Group research drove the creation of a managed markets launch kit that packaged the product’s “body of evidence” in a fresh new way, providing payers with easy access to relevant research. A mix of PowerPoint and written materials, including flashcards, equipped account managers with multiple clinical materials that could be quickly customized for client presentations.
Through segmentation, Medicaid was identified as a prime target for asthma medication Xopenex, even though it was highly restricted at the time by the provider, requiring PDLs and prior authorizations. To build physician loyalty and eliminate barriers to access, RADical Group highlighted the risks of the disease to minority children, including hospitalization, morbidity and mortality rates. Marketing materials included customized brochures with state-specific prior authorization or step therapy process requirements.
As an infused drug, Orencia is classified as “Part B” medical drug versus a pharmacy drug, which translates into completely different channels of distribution and requirements for managed markets reimbursement. To reduce obstacles for rheumatologists, RADical Group developed materials that walked physicians through the reimbursement process. Intensive training for field representatives and account managers ensured that they could walk physicians through what is often a complex process.
RADical Group’s expertise in publication planning — including articles and supplements — allows you to reach managed markets opinion leaders with relevant messaging in a highly cost-effective way. Publishing can be a vital core component of product strategic planning both pre- and post-launch.